N-acetylcysteine as a feed additive to counteract ochratoxin A toxicity in poultry
Muntaha Tanveer1,2, Muhammad Imran2, Muhammad Kashif Saleemi2
1Department of Zoology, Wildlife and Fisheries, Faculty of Sciences, University of Agriculture, Faisalabad, Pakistan.
Abstract:
Ochratoxin A (OTA), a toxic metabolite produced by Aspergillus and Penicillium species, is a significant contaminant in poultry feed and poses serious health risks by impairing growth, immunity, and organ function in broilers. This study was designed to evaluate the protective efficacy of N-acetylcysteine (NAC), a known antioxidant and glutathione precursor, against OTA-induced clinicopathological and histopathological changes in broiler chickens. A total of 125 day-old broiler chicks were randomly divided into five equal groups: control, OTA (400 µg/kg), NAC (100 mg/kg), OTA plus NAC, and OTA plus a commercial toxin binder. Birds were monitored over a five-week period for clinical signs, feed intake, body weight, gross and microscopic lesions, and serum biochemical parameters. Results revealed that OTA exposure significantly (p ≤ 0.05) reduced feed intake, weight gain, and serum protein levels, while increasing liver and kidney enzyme markers (ALT, AST, urea, and creatinine), indicating hepatic and renal impairment. Gross (macroscopic) and histological examinations confirmed organ damage in the OTA-treated group, with enlarged, pale, and friable livers, swollen kidneys, hepatocyte necrosis, and renal tubular degeneration. Notably, NAC supplementation mitigated these adverse effects, restoring performance, serum biochemistry, and tissue architecture that were comparable to those observed in the control group. The efficacy of NAC was comparable to the commercial toxin binder. These findings suggest that NAC is a promising and cost-effective feed additive for protecting poultry against OTA-induced toxicity.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Prevention of Further Absorption of Poison
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...


